title: [Tamoxifen and endometrial adenocarcinoma].
abstract: The authors report a case of endometrial carcinoma treated with tamoxifen introduced after normal initial uterine curettage. Based on recent experimental and clinical data, the importance of a gynecological follow-up in anti-estrogen therapy is emphasized.
authors.affiliation: Département de chirurgie oncologique, Centre Régional de Lutte Contre le Cancer Paul-Strauss, Strasbourg, France.
authors.forename: J F
authors.initials: JF
authors.lastname: Rodier
authors.forename: E
authors.initials: E
authors.lastname: Camus
authors.forename: J C
authors.initials: JC
authors.lastname: Janser
authors.forename: R
authors.initials: R
authors.lastname: Renaud
authors.forename: D
authors.initials: D
authors.lastname: Rodier
mesh_terms: D000230:Adenocarcinoma / Q000139:chemically induced*; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D013629:Tamoxifen / Q000009:adverse effects* / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000139:chemically induced*
chemical_list: D013629:Tamoxifen
vernacular_title: Tamoxifène et adénocarcinome endométrial.